InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Patzer Eric, Director. Director active across 1 company, notably Aridis Pharmaceuticals, Inc.. In total, 4 reports have been published. Split: 3 buys · 0 sell. Total volume traded: €89k. Activity tracked since 27 July 2021. The latest transaction was disclosed on 24 June 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations
Eric Patzer serves as a Director at Aridis Pharmaceuticals, Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. Eric brings valuable experience in the pharmaceutical sector, enabling him to assess growth and innovation opportunities. His role is crucial in ensuring compliance and transparency in governance.